Gilead appoints Sanofi official Dietmar Berger
Berger specialized in cancer long before joining Genentech, holding oncology global clinical development roles at Amgen and ...
Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Sanofi ( (SNY) ) has issued an announcement.
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...
Sanofi CEO Paul Hudson says, "AI is a huge opportunity, and we can't be deniers." ...
French drug major Sanofi (SNY) announced Friday that the U.S. Food and Drug Administration has granted Breakthrough Therapy ...
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of ...
A drug developed by Sanofi raised platelet counts and reduced bleeding episodes in patients with a rare autoimmune disorder ...
The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...
SHANGHAI, Dec 2 (Reuters) - Sanofi plans to invest around 1 billion euros ($1.05 billion) to build a new insulin production ...
Sanofi just made its largest investment thus far in China. The company has committed just over $1 billion to build a new ...
Sanofi has reported that the Phase III LUNA 3 trial of rilzabrutinib for the treatment of persistent or chronic immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback